MRI-whole body, whole muscles – precisely the answer
AMRA Medical invites you to meet at Virtual MYO MRI Imaging in Neuromuscular Disease Conference 2021. As a gold sponsor, in the exhibitor booth and the sponsor space, AMRA will share our deep clinical trials and regulatory experience providing MRI biomarkers in studies for new cures.
From AMRA’s MRI perspective, all human bodies are unique. The hallmark of neuromuscular disorders (NMDs) is the progressive loss of muscle volume with increased intramuscular fat. Different NMDs express unique patterns of decline throughout the disease, and often present heterogeneously.
What does this mean to researchers in the NMD space? As long as someone is having an MRI – get the full picture. AMRA can deliver single muscles, muscle groups, and single MRI slice measurements. But why stop there? A person is not a single muscle or a single slice. A person is a whole body. So, scan and volumetrically measure muscles and fatty infiltration throughout the entire body. Use AMRA’s MRI method to potentially move drug treatment approval forward faster.
AMRA’s regulatory compliant processes, paired with our documented precision and accuracy, are the safe and reliable way to see small changes potentially sooner than functional tests.
AMRA® Researcher enables longitudinal volumetric assessment of muscle volume, muscle fat infiltration, and muscle fat replacement.
- Directly measuring end organ effects with the possibility to follow heterogeneous disease distribution
- Fast and easy MRI scan protocols, compatible with all major scanner manufacturers (GE, Philips, Siemens)
- Accurate & precise whole body 3D volumetric measurements of individual muscles and muscle groups
AMRA measures 36+ different muscles longitudinally, optimized to the characteristic involvement pattern of the neuromuscular disorder studied.